Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process

• Published in: Molecular and cellular neuroscience 2009-02, Vol.40 (2), p.217-224
• Main Authors: Pera, M., Martínez-Otero, A., Colombo, L., Salmona, M., Ruiz-Molina, D., Badia, A., Clos, M.V.
• Format: Article
• Language: English
• Subjects: Acetylcholinesterase; Acetylcholinesterase - genetics; Acetylcholinesterase - metabolism; AChE peripheral site; AChE peripheral site blockers; Amyloid - chemistry; Amyloid - metabolism; Amyloid aggregation process; Animals; Anticoagulants - metabolism; Cattle; Coumarins - metabolism; Gerstmann-Straussler-Scheinker Disease - metabolism; Gerstmann-Straussler-Scheinker Disease - pathology; Gerstmann-Sträussler-Scheinker disease; Glycoproteins - genetics; Glycoproteins - metabolism; Humans; Microscopy, Atomic Force; Particle Size; Peptide Fragments - chemistry; Peptide Fragments - genetics; Peptide Fragments - metabolism; Plaque, Amyloid - chemistry; Plaque, Amyloid - metabolism; Prion protein; Prions - chemistry; Prions - genetics; Prions - metabolism; PrP82-146
• ISSN: 1044-7431; 1095-9327
• DOI: 10.1016/j.mcn.2008.10.008

Acetylcholinesterase (AChE) triggers beta amyloid plaques formation and is associated with amyloid plaques in the brain. Recent studies have demonstrated that AChE promotes the aggregation of PrP106-126, a peptide deduced from the prion protein sequence. In the present study we show that AChE triggers also the fibrillization of the main component of the amyloid plaques -the peptide spanning residues 82-146 (PrP82-146)- found in patients with Gerstmann-Sträussler-Scheinker disease (GSS). The kinetics of PrP82-146 aggregate formation was directly correlated with AChE concentration and mature fibrils showed the tinctorial and optical properties of amyloid. Atomic force microscopy analysis showed that oligomer and amyloid fibril formation were significantly accelerated by AChE. This effect was mediated by the peripheral site of the enzyme since propidium iodide inhibited the fibrillization process. Present results strongly support the role of AChE in triggering amyloidogenesis and the potential therapeutic relevance of peripheral site blocker compounds.